Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 183

1.
2.

Acid sphingomyelinase gene deficiency ameliorates the hyperhomocysteinemia-induced glomerular injury in mice.

Boini KM, Xia M, Li C, Zhang C, Payne LP, Abais JM, Poklis JL, Hylemon PB, Li PL.

Am J Pathol. 2011 Nov;179(5):2210-9. doi: 10.1016/j.ajpath.2011.07.019. Epub 2011 Sep 3.

3.

Inhibition of ceramide-redox signaling pathway blocks glomerular injury in hyperhomocysteinemic rats.

Yi F, Zhang AY, Li N, Muh RW, Fillet M, Renert AF, Li PL.

Kidney Int. 2006 Jul;70(1):88-96. Epub 2006 May 10.

4.

Protective role of growth hormone against hyperhomocysteinemia-induced glomerular injury.

Li C, Xia M, Abais JM, Liu X, Li N, Boini KM, Li PL.

Naunyn Schmiedebergs Arch Pharmacol. 2013 Jun;386(6):551-61. doi: 10.1007/s00210-013-0848-1. Epub 2013 Mar 27.

5.

Instigation of NLRP3 inflammasome activation and glomerular injury in mice on the high fat diet: role of acid sphingomyelinase gene.

Boini KM, Xia M, Koka S, Gehr TW, Li PL.

Oncotarget. 2016 Apr 5;7(14):19031-44. doi: 10.18632/oncotarget.8023.

6.

Nod-like receptor protein 3 (NLRP3) inflammasome activation and podocyte injury via thioredoxin-interacting protein (TXNIP) during hyperhomocysteinemia.

Abais JM, Xia M, Li G, Chen Y, Conley SM, Gehr TW, Boini KM, Li PL.

J Biol Chem. 2014 Sep 26;289(39):27159-68. doi: 10.1074/jbc.M114.567537. Epub 2014 Aug 19.

7.

Epithelial-to-mesenchymal transition in podocytes mediated by activation of NADPH oxidase in hyperhomocysteinemia.

Zhang C, Xia M, Boini KM, Li CX, Abais JM, Li XX, Laperle LA, Li PL.

Pflugers Arch. 2011 Sep;462(3):455-67. doi: 10.1007/s00424-011-0981-y. Epub 2011 Jun 7.

8.

Hydrogen sulfide ameliorates hyperhomocysteinemia-associated chronic renal failure.

Sen U, Basu P, Abe OA, Givvimani S, Tyagi N, Metreveli N, Shah KS, Passmore JC, Tyagi SC.

Am J Physiol Renal Physiol. 2009 Aug;297(2):F410-9. doi: 10.1152/ajprenal.00145.2009. Epub 2009 May 27.

9.

Podocyte injury and glomerulosclerosis in hyperhomocysteinemic rats.

Yi F, dos Santos EA, Xia M, Chen QZ, Li PL, Li N.

Am J Nephrol. 2007;27(3):262-8. Epub 2007 Mar 30.

PMID:
17396029
10.

Contribution of endogenously produced reactive oxygen species to the activation of podocyte NLRP3 inflammasomes in hyperhomocysteinemia.

Abais JM, Xia M, Li G, Gehr TW, Boini KM, Li PL.

Free Radic Biol Med. 2014 Feb;67:211-20. doi: 10.1016/j.freeradbiomed.2013.10.009. Epub 2013 Oct 16.

11.

Inhibition of hyperhomocysteinemia-induced inflammasome activation and glomerular sclerosis by NLRP3 gene deletion.

Xia M, Conley SM, Li G, Li PL, Boini KM.

Cell Physiol Biochem. 2014;34(3):829-41. doi: 10.1159/000363046. Epub 2014 Aug 20.

12.

Activation of Nod-like receptor protein 3 inflammasomes turns on podocyte injury and glomerular sclerosis in hyperhomocysteinemia.

Zhang C, Boini KM, Xia M, Abais JM, Li X, Liu Q, Li PL.

Hypertension. 2012 Jul;60(1):154-62. doi: 10.1161/HYPERTENSIONAHA.111.189688. Epub 2012 May 29.

13.

Protective Action of Anandamide and Its COX-2 Metabolite against l-Homocysteine-Induced NLRP3 Inflammasome Activation and Injury in Podocytes.

Li G, Xia M, Abais JM, Boini K, Li PL, Ritter JK.

J Pharmacol Exp Ther. 2016 Jul;358(1):61-70. doi: 10.1124/jpet.116.233239. Epub 2016 May 11.

14.

NADPH oxidase-mediated triggering of inflammasome activation in mouse podocytes and glomeruli during hyperhomocysteinemia.

Abais JM, Zhang C, Xia M, Liu Q, Gehr TW, Boini KM, Li PL.

Antioxid Redox Signal. 2013 May 1;18(13):1537-48. doi: 10.1089/ars.2012.4666. Epub 2012 Dec 10.

15.

Genetic background conversion ameliorates semi-lethality and permits behavioral analyses in cystathionine beta-synthase-deficient mice, an animal model for hyperhomocysteinemia.

Akahoshi N, Kobayashi C, Ishizaki Y, Izumi T, Himi T, Suematsu M, Ishii I.

Hum Mol Genet. 2008 Jul 1;17(13):1994-2005. doi: 10.1093/hmg/ddn097. Epub 2008 Mar 25.

PMID:
18364386
16.
17.

Redox signaling via lipid raft clustering in homocysteine-induced injury of podocytes.

Zhang C, Hu JJ, Xia M, Boini KM, Brimson C, Li PL.

Biochim Biophys Acta. 2010 Apr;1803(4):482-91. doi: 10.1016/j.bbamcr.2009.12.006. Epub 2009 Dec 28.

18.

Alterations of retinal vasculature in cystathionine-Beta-synthase mutant mice, a model of hyperhomocysteinemia.

Tawfik A, Al-Shabrawey M, Roon P, Sonne S, Covar JA, Matragoon S, Ganapathy PS, Atherton SS, El-Remessy A, Ganapathy V, Smith SB.

Invest Ophthalmol Vis Sci. 2013 Feb 1;54(2):939-49. doi: 10.1167/iovs.12-10536.

19.

Induction of podocyte-derived VEGF ameliorates podocyte injury and subsequent abnormal glomerular development caused by puromycin aminonucleoside.

Ma J, Matsusaka T, Yang HC, Zhong J, Takagi N, Fogo AB, Kon V, Ichikawa I.

Pediatr Res. 2011 Jul;70(1):83-9. doi: 10.1203/PDR.0b013e31821bdf1c.

20.

Hyperhomocysteinemia associated with decreased renal transsulfuration activity in Dahl S rats.

Li N, Chen L, Muh RW, Li PL.

Hypertension. 2006 Jun;47(6):1094-100. Epub 2006 Apr 24.

Supplemental Content

Support Center